🚀 FDA Goes All-In on AI: Cutting Drug Review Times from Days to Minutes!
BREAKING: The FDA just announced an agency-wide AI rollout with an ambitious deadline—full implementation by June 30, 2025—after a groundbreaking pilot proved AI could slash scientific review times.
🔬 Why It Matters:
AI-assisted reviews reduced tasks that took 3 days to just minutes
Frees scientists from tedious paperwork, speeding up life-saving therapies
Secure, unified AI system will expand across all FDA centers
💡 FDA Commissioner Dr. Makary:
"We can’t afford more talk—AI is transforming drug reviews NOW. This isn’t theoretical; it’s already working."
📅 What’s Next?
Immediate deployment across drug, medical device & food safety reviews
Future upgrades for custom AI tools per department
Strict security protocols to protect sensitive data
👨💻 Led by:
Jeremy Walsh, FDA’s first Chief AI Officer (ex-health/intel tech leader)
Sridhar Mantha, CDER informatics expert
#AIinHealthcare #FDA #DrugDevelopment #MedicalInnovation #ArtificialIntelligence #PublicHealth #FutureOfMedicine #HealthTech
Comments
Post a Comment